Skip to main content
. 2024 Jul 8;25(4):bbae321. doi: 10.1093/bib/bbae321

Figure 6.

Figure 6

ROC curve comparison of DrugMetric and QED in identifying FDA-approved but clinically toxic molecules from the ClinTox dataset. The analysis targeted a subset of 17 FDA-approved toxic compounds. DrugMetric outperformed QED with an ROC AUC of 0.83 compared to 0.39 for QED.